Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

BUENOS AIRES, April 21, 2025--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative ...

GridX, Latin America’s largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative startups across three strategic U.S. cities ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Alis Biosciences says its goal is to return to investors billions of dollars stuck on the balance sheets of “moribund” ...

Most investors can distinguish between bad, good, and even-better investment prospects ... next year, pushing the biotech company out of the red and into the black in the process.

Jonathan Faison, Head of the ROTY Biotech Community, discusses volatility and growth in biotech, advocating for a portfolio ...

BUENOS AIRES, April 21, 2025--(BUSINESS WIRE)--GridX, Latin America's largest biotechnology investment fund and company builder, is set to begin its international Roadshow featuring 21 innovative ...

After struggling through a rough patch, the biotech industry seems to be staging a comeback. Several biotech firms have gone public this year, and those focused on obesity treatments, gene ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.